Literature DB >> 11708359

The ethics of elective (non-therapeutic) ventilation.

A Browne1, G Gillett, M Tweeddale.   

Abstract

Elective ventilation (EV) is ventilation applied, not in the interest of patients, but in order to secure transplantable organs. It carries with it a small risk that patients who would otherwise have died will survive in a persistent vegetative state. Is EV ever justifiable? We argue: (1) The only thing which can justify exposing patients to risk not taken for their benefit is their consent, and we cannot rely on implied consent or third party consent in the case of EV. Thus absent explicit consent of patients, EV is not justifiable. (2) It is not clear that explicit consent should be sought, or where it is offered honoured, given the potential EV has for deterring organ donors and causing stress to staff and families.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health; Philosophical Approach; Professional Patient Relationship

Mesh:

Year:  2000        PMID: 11708359     DOI: 10.1111/1467-8519.00179

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  4 in total

1.  Organ and tissue donation in the intensive care unit.

Authors:  Graeme M Rocker
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

2.  What does "presumed consent" might presume? Preservation measures and uncontrolled donation after circulatory determination of death.

Authors:  Pablo de Lora
Journal:  Med Health Care Philos       Date:  2014-08

Review 3.  Controversies in defining and determining death in critical care.

Authors:  James L Bernat
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

Review 4.  Ethical and legal implications of elective ventilation and organ transplantation: "medicalization" of dying versus medical mission.

Authors:  Paola Frati; Vittorio Fineschi; Matteo Gulino; Gianluca Montanari Vergallo; Natale Mario Di Luca; Emanuela Turillazzi
Journal:  Biomed Res Int       Date:  2014-07-14       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.